Ear Drops - 0.1%

Ear Drops - 0.5%

Ear Drops - 0.3%

5% (or 10%) ear drops (in propylene glycol)

1% solution

Ear Drops

Eye/ear drops containing dexamethasone 0.05%, framycetin sulphate 0.5% & gramicidin 0.005%

Ear Spray

Ear Drops

Ear drops containing hydrocortisone 1%, neomycin sulph. 0.439% & polymyxin B sulph. 10,000 units/ml

Ear Drops^OTC

^{Should be purchased for self-care. Drops containing simple remedies such as olive oil, almond oil and sodium bicarbonate are available.}

Ear Drops - 5%^OTC

Nasal Spray - 50 microgram

0.1% eye/ear/nose drops (betamethasone sod. phos.)

27.5 microgram / dose nasal spray.

N.B. Take care to
avoid confusion with fluticasone propionate

50 microgram / dose nasal spray^OTC

400 microgram unit dose nasal drops

N.B. Take care to avoid confusion with fluticasone
furoate

Nasal Spray - 50 microgram

55 microgram metered dose nasal spray^OTC

0.1% nasal spray (140 micrograms/metered spray)

Nasal Spray - 4%

Nasal Spray - 0.1%

Nasal Spray - 0.03%

0.9% nasal drops

0.5% & 1% nasal drops

Nasal Ointment - 2% 

First choice for use in MRSA eradication.

Cream

MRSA Only

Paste 1.25cm x 100cm & 2.5cm x 100cm impregnated gauze

Oral Rinse - 0.15%

Spray

Paste^OTC containing carmellose sodium 16.7%, pectin 16.7%
& gelatin 16.7% in plastibase

Mucoadhesive Buccal Tablets - 2.5mg^OTC

MHRA Drug Safety Update (Dec 2018): Hydrocortisone muco-adhesive buccal tablets: should not be used off-label for adrenal insufficiency in children due to serious risks

Oral Gel - 8.7% (Bonjela)^OTC

0.2% gel & 0.025% mouthwash (Gengigel)

For limited second-line use on specialist advice in the treatment of orofacial granulomatosis, severe oral ulceration and mucositis secondary to mmunosuppression where conventional treatments are unsuitable or
have failed.

MuGard®
Restricted to use in patients who are currently on sunitinib (Sutent®) treatment, and is cheaper than treatment that is currently used.

1 dose=1 x 15ml Caphosol A + 1 x 15ml Caphosol B mixed
together

CD&D APC Grey List: For limited use in patients having chemo-radiotherapy or radiotherapy to malignancies of the oral cavity, hypopharnyx and oro-pharynx on specialist recommendation.

20mg tablets

For Periodontitis

Oral Gel - 24mg/ml

Gel not recommended under 4m of age due to choking risk

MHRA Drug Safety Update (June 2016): Topical miconazole, including oral gel: reminder of potential for serious interactions with warfarin

MHRA Drug Safety Update (Sept 2017): Miconazole (Daktarin): over-the-counter oral gel contraindicated in patients taking warfarin

Suspension - 100,000units/ml

100mg/1ml oral suspension

50mg muco-adhesive buccal tablets

Restricted to use in immunocompromised patients with severe oropharyngeal candidiasis, where the use of other antifungal agents e.g. nystatin, fluconazole is not appropriate and for use on the advice of microbiologists.

Tablets & suspension – see section 5.3.2

1.4 mg lozenges^OTC

Lozenges (benzocaine 10mg + cetylpyridinium Cl 1.4mg)^OTC

Mouthwash - 0.2%

Dental Gel - 1%

2% oral gel^u

For hospital use in the prevention of ventilator-associated pneumonia in adult patients who are ventilated (for >48 hours).

0.1% mouthwash

Solution tablets containing antimicrobial, flavouring and
colouring agents

Toothpaste containing triclosan - for use in MRSA eradication. If Mentadent P is not available, Colgate Total is a suitable alternative.

Oral Spray

Preferred to Glandosane as it is less likely to damage tooth enamel

Oralbalance Gel

Prescribable on the NHS in primary care as a Borderline Substance.

Spray

Sugar-free pastilles containing malic acid

5mg tablets

Treatment to be initiated with specialist advice.

Salivary gel and toothpaste.

The gel, but not the toothpaste, is prescribable on the NHS in primary care as a Borderline Substance.